Liver cancer patients exhibiting high H2A.Z.1 expression and TP53 mutations have the worst prognosis and highest risk of tumor progression, while those with low H2A.Z.1 expression and wild-type TP53 show the best prognosis. Here, TP53 is linked to neoplasm.